MAP2K1 Gene Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations (NCT04488003) | BioMed Valley Discoveries, Inc | 2021-01-07 |
| Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer (NCT03087071) | M.D. Anderson Cancer Center | 2017-12-29 |
Track MAP2K1 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.